Alveus Therapeutics partnered with Medable to embed agentic AI into clinical trial oversight for obesity and metabolic studies. The integration aims to automate trial-risk flagging and decision support, reducing the time spent on manual statistical work and enabling faster operational adjustments as data arrive. For biotech sponsors, the update highlights a practical application of AI beyond analytics—using intelligent agents to monitor trial execution signals and help teams manage protocol risks earlier. The approach also reflects growing interest in zero-code or low-friction workflow automation for trial operations and study conduct.